Weiss Multi-Strategy Advisers’s Immunomedics Inc IMMU Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-201,011	Closed	-$17.1M	–	847
2020 Q3	$17.1M	Buy	201,011 +190,348	+1,785%	+$9.63M	0.46%	60
2020 Q2	$378K	Buy	+10,663	New	+$312K	0.01%	483
2018 Q2	–	Sell	-75,000	Closed	-$1.1M	–	716
2018 Q1	$1.1M	Buy	75,000 +15,000	+25%	+$245K	0.03%	408
2017 Q4	$970K	Sell	60,000 -40,000	-40%	-$472K	0.02%	445
2017 Q3	$1.4M	Hold	100,000	–	–	0.05%	348
2017 Q2	$883K	Sell	100,000 -10,000	-9%	-$70.2K	0.04%	373
2017 Q1	$712K	Hold	110,000	–	–	0.03%	426
2016 Q4	$404K	Buy	110,000 +33,000	+43%	+$97.6K	0.02%	346
2016 Q3	$250K	Buy	77,000 +4,100	+6%	+$11.5K	0.02%	386
2016 Q2	$169K	Sell	72,900 -7,100	-9%	-$23.7K	0.01%	382
2016 Q1	$200K	Sell	80,000 -20,000	-20%	-$45K	0.01%	429
2015 Q4	$307K	Buy	+100,000	New	+$279K	0.02%	332

Weiss Multi-Strategy Advisers's IMMU Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 201,011 shares — an estimated $17.1M sold.

Weiss Multi-Strategy Advisers first reported a position in IMMU in Q4 2015 and held it in 12 quarters. The position peaked at $17.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Weiss Multi-Strategy Advisers reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 201,011 Immunomedics Inc shares in Q4 2020, an estimated $17.1M.
Weiss Multi-Strategy Advisers first reported a position in Immunomedics Inc in Q4 2015 and held it in 12 quarters.
Weiss Multi-Strategy Advisers's Immunomedics Inc position peaked at $17.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.